CAS: 983-85-7; Acetyloxymethyl (2S,5R,6R)-3,3-Dimethyl-7-Oxo-6-[(2-Phenylacetyl)Amino]-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate

该化合物是一种该化合物是一种青蒿素,其特点是其稳定性增强,口服生物利用率比其母体化合物更加稳定,口服生物利用率比其母体化合物更适合某些临床应用.Penamecillin在血液中被水解,以释放活性苯丙西林,该物质通过抑制细菌细胞壁合成而进行杀菌活动.其活动范围主要针对模范生物,包括Streptococccus和易感染的Staphylococus菌株.这种配方在吸收和药用植物基因学方面提供了优势,提供了更一致的治疗效果.在口服治疗方面,Penamecillin通常用于中度的轻度感染.它的临床效用得到其可预测的代谢和既定安全特征的支持.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

    • 合成目标产物 Penamecillin 主要起始原料 Chloromethyl Acetate And Penicillin G Potassium Salt
    • (文献来源)合成步骤主要原料 Chloromethyl Acetate 和 Penicillin G Potassium Salt
    📜溴甲基乙酸酯,6β-(2-Phenyl-Acetylamino)-Penicillanic Acid; Triethylamine Salt 以 N,N-二甲基甲酰胺 作为反应溶剂,化学反应生成 培那西林
    参考文献:379.一些新的青霉素衍生物
    标题:379.一些新的青霉素衍生物
    摘要:
    DOI:10.1039/jr9650002127

    海关参考信息

    专利信息


    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    专利号:US-2025002508-A1
    优先权日:2020-05-05
    标题 :Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
    发明人:HECKER SCOTT J; BOYER SERGE HENRI; BIO MATTHEW M; FANG YUANQING; GONZALES DE CASTRO ANGELA; LEFORT LAURENT; ZHU ZUOLIN; LINDER THOMAS
    权利人:QPEX BIOPHARMA INC
    摘要:Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

    专利号:US-9907753-B2
    优先权日:2010-03-19
    标 题 :Lipid vesicle compositions and methods of use
    发明人:IRVINE DARRELL J; MOON JAEHYUN
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.

    专利号:US-2015150995-A1
    优先权日:2012-08-09
    标题:Conjugated anti-microbial compounds and conjugated anti-cancer compounds and uses thereof
    发明人:TAFT III KARL MILTON; ENGELKING JARRED ROY
    权利人:PONO CORP
    摘要:Disclosed herein are synthesis methods for generation of conjugated anti-microbial compounds and conjugated anti-cancer compounds. Several embodiments, related to the uses of such compounds in the treatment of infections, in particular those caused by drug-resistant bacteria. Some embodiments relate to targeting cancer based on the metabolic signature of tumor cells.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Agersborg HP, Batchelor A, Cambridge GW, Rule AW. The pharmacology of penamecillin. Br J Pharmacol Chemother. 1966 Mar;26(3):649-55. doi: 10.1111/j.1476-5381.1966.tb01844.x.
    2: Gibaldi M, Schwartz MA. The pharmacokinetics of penamecillin. Br J Pharmacol Chemother. 1966 Dec;28(3):360-6. doi: 10.1111/j.1476-5381.1966.tb01904.x.
    3: Matuz M, Benko R, Doro P, Hajdu E, Soos G. Non-prescription antibiotic use in Hungary. Pharm World Sci. 2007 Dec;29(6):695-8. doi: 10.1007/s11096-007-9132-0. Epub 2007 May 25. 81(1):1-8. doi: 10.1016/s0301-2115(98)00138-9. 48(2):54-61. Hungarian. 10(3):235-63. doi: 10.1504/IJBRA.2014.060761. 10(12):2977-82. doi: 10.1002/chem.200305627. 13(3):215-9. German. 55(4):221-8. Hungarian. 51(1):38-42. Hungarian.

    合成参考文献


    摘要:S6 | ITNANTIBIOTIC | Antibiotic List from the ITN MSCA ANSWER | DOI:10.5281/zenodo.2621956
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知